Sumitomo Dainippon Pharma : Sep. 08, 2021 Frontier Business Meeting - FBO Showcase - transcript(PDF/18,634KB)

Frontier Business Meeting - FBO Showcase -

[Date]	Wednesday September 8, 2021 13:00 - 15:03
	(Total: 123 minutes, Presentation: 73 minutes, Q&A: 50 minutes)
[Venue]	Webcast
[Number of Speakers]	11
	Hiroshi Nomura	Representative Director, President, and CEO
	Toru Kimura	Representative Director, Executive Vice President,
		Chief Scientific Officer
	Hiroyuki Baba	Senior Executive Officer
	Takehiko Nomura	Senior Director, Frontier Business Office
	Seiji Hori	Officer, Business Development & Portfolio Strategy,
		Frontier Business Office
	Tetsuya Uyama	Officer, Frontier Business Office
	Yukako Nishimaki	Officer, Business Promotion, Frontier Business Office
	Yasushi Ochiai	Officer, Planning and Development, Frontier
		Business Office
	Miwako Harada	Senior Director, Corporate Communications
	Mr. Junichi Kato	COO, Aikomi Ltd.
	Dr. Mark Kasuya	CEO, MELTIN

1

Presentation

Harada: Thank you very much for taking time out of your busy schedule to join us today for the Sumitomo Dainippon Pharma Co., Ltd. Frontier Business Meeting ‐ FBO Showcase ‐.

FBO is the abbreviation for Frontier Business Office. We would like to introduce the vision, portfolio, and major projects of Frontier Business.

Today's presentation material was emailed to you and is also available on our website. You can also see it on the screen; however, the slides for each part are not numbered sequentially, so please note that the page numbers are different from those in your handouts.

There will be time for questions after the presentation. Please note that this meeting will be recorded for later distribution on the website.

I would now like to introduce today's attendees.

From left to right, the first row of the screen: Representative Director, President and CEO, Mr. Nomura. Representative Director, Executive Vice President, Chief Scientific Officer, Dr. Kimura. Senior Executive Officer, in charge of Frontier Business, Mr. Baba. Second row, from left, Senior Director, Frontier Business Office, Dr. Nomura. Officers Mr. Hori, Mr. Uyama, Ms. Nishimaki, and Mr. Ochiai. I am Harada of Corporate Communications and will serve as moderator today.

We also invited some project partners. Mr. Kato, COO of Aikomi Ltd. Dr. Kasuya, CEO of MELTIN. Thank you.

President, Mr. Nomura will begin our presentation with an introduction.

2

Hiroshi Nomura: Everyone, my name is Nomura, the President. Thank you very much for taking time out of your busy schedule to join us today at the Frontier Business Meeting ‐ FBO Showcase ‐.

I am very grateful for this opportunity to present our Frontier Business as a whole today, although we have been partially informing you about it in our earnings announcement and other press releases.

We originally explored healthcare solutions outside of medicine as part of our Beyond the Pills initiative, and our employees came up with many ideas as we formulated our mid‐term business plan started in 2018. We have positioned these ideas as Frontier Business and have decided to tackle it in earnest company wide.

I believe that some of the themes that we will present to you today were included at that time. The Frontier Business aims to provide solutions to health issues that cannot be solved by medicines in areas that are close to our businesses. We plan to carefully nurture this business to make it the next growth engine along with the pharmaceutical business.

3

To this end, we have established the Frontier Business Office, a division dedicated to this business, starting in April 2019. This field is different from pharmaceutical research and development in that if we do not quickly identify clinical and other needs and move ahead, we will get left behind the times. I believe it is needed that there is always a close connection between the needs of the field and what we are doing, and that means of solving problems are technologically new.

We are constantly reviewing and revising our running projects from this perspective.

We will proceed with the Frontier Business in areas that are close to our existing businesses. However, we believe that we will be able to create solutions in areas where we are not strong, such as new technologies of software and devices, by working with partners and utilizing the experience of both companies.

We would like to expand the business to cover a wide range of Patient Journey in healthcare from prevention and treatment, to prognosis, and we expect to expand this business in Japan, US, and China.

Now, I would like to ask for your participation in the upcoming presentations and also in the thematic presentations.

Harada: Next, Senior Executive Officer, Mr. Baba will explain the future vision of the Frontier Business.

Baba: I'm Baba, in charge of the Frontier Business. Thank you very much again for your time today.

Although it is a bit presumptuous to talk about a vision for the future, I think it is important to have a vision or image of what kind of society we would like to have in the future when planning and promoting the Frontier Business. So I would like to share my thoughts on this.

4

It is a little sudden to say, but the key concept here is "good people." This word has many definitions, and in some cases it may be used in a negative way, but here we are thinking of something like a utopia, a world full of people with big hearts, good hearts, compassion, and kind hearts.

Of course, if there were only such people, society would become stagnant, so it may be a matter of degree. However, when we consider various trends in society, for example, various incidents occur due to tangled human relationships. There are quite a few tragic incidents that occur in families.

Some people may say that this is the way it has always been, and in a sense, it is human nature, so there is nothing we can do about it.

However, it is said that it is human relationships that largely determine whether people are happy or unhappy. In the next era, or when we move on to the next phase of civilization, I think it would be a good idea to address the fundamental issues of human society with a big concept such as increasing the number of "good people," which may be a bit ridiculous.

5